Delivery Order SPE2DE24D0013-SPE2D625F2LKH
- Not listed
- This delivery order, valued at $8,191.89, was awarded on September 18, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract represents a Firm Fixed Price delivery order with no set-aside designation, with an ultimate completion date of September 25, 2025. The work will be performed in Sunnyvale, California, and is funded by the Defense Department's Medical Supply Chain organization. This award is likely associated with one of Cepheid's...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a firm fixed-price delivery order valued at $3,708.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 12, 2025, carries no set-aside designation. This award represents a discrete delivery order under one of Cepheid's larger indefinite delivery vehicle contracts with the...
- This delivery order, valued at $1,277.84, was awarded on August 28, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 5, 2025. Performance will take place in Sunnyvale, CA. The funding agency is the Defense Department's Medical Supply Chain organization. This delivery order likely represents a task order issued under one...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $4,620 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency component) on September 5, 2025, with an ultimate completion date of September 12, 2025. The contract, designated XPRS-COV2-10, carries no set-aside designation and represents work to be performed in Sunnyvale, California. This delivery order likely draws from one of Cepheid's two significant Indefinite...
- This delivery order, awarded July 30, 2025, by the Defense Logistics Agency (under the Medical Supply Chain operations) to Cepheid Inc., carries a firm fixed-price ceiling value of $27,235.80 with an ultimate completion date of August 6, 2025. The contract utilizes no set-aside designation and is performed in Sunnyvale, California, where Cepheid maintains its headquarters. Cepheid, a for-profit manufacturer of molecular diagnostic solutions, will deliver products or services under this...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,791.90 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and reagents to federal healthcare systems. The work will be performed in Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,854.00 by the Medical Supply Chain (a Defense agency) on May 21, 2025, with an ultimate completion date of May 29, 2025. The contract, issued without set-aside designation under contract number GXGBSLBXC-10, is to be performed in Sunnyvale, California. This delivery order represents a discrete procurement action under one of Cepheid's existing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $31,775.10 by the Defense Department's Medical Supply Chain organization on April 24, 2025. The contract, designated XPRSMVP-10, has an ultimate completion date of May 1, 2025 and carries no set-aside designation. The work will be performed at Cepheid's Sunnyvale facility. This delivery order falls under one of Cepheid's larger Indefinite Delivery...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2LKHDelivery Order
This delivery order, valued at $27.2K, was awarded on September 3, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The order is a firm fixed-price award with an ultimate completion date of September 10, 2025, funded by the Medical Supply Chain division within the Department of Defense. The contract carries no set-aside designation and is to be performed in Sunnyvale, California. This delivery order falls under Cepheid's existing Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network 6, a single-award IDV valued at approximately $32.8M and extending through September 30, 2030, which provides molecular diagnostic testing system reagents and assays to the federal healthcare system. Cepheid specializes in advanced molecular diagnostic technologies and has established itself as a primary supplier of diagnostic equipment and reagent kits to multiple federal agencies, including the Department of Veterans Affairs, Defense Logistics Agency, and Defense Health Agency. The company's product portfolio centers on GeneXpert diagnostic systems and associated molecular testing solutions for infectious diseases, including COVID-19, influenza, RSV, and other conditions requiring rapid point-of-care detection. This delivery order represents continued procurement under the established IDV framework, supporting the Defense Health Agency's diagnostic and laboratory testing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.2k | 9/3/25 |